Publications by authors named "In-Jae Oh"

Claim this Profile
G
Geriatric screening tools in older patients undergoing concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.
Yong-Hyub Kim, Jae-Uk Jeong, Sung-Ja Ahn, Young-Chul Kim, In-Jae Oh, Hyung-Joo Oh

J Geriatr Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Follow-Up Analysis of First-Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Real-World Multicenter Prospective Cohort Study.
Yechan Song, Myeong Geun Choi, Yeon Joo Kim, Jae Cheol Lee, Wonjun Ji, In-Jae Oh

Thorac Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal changes in tongue color during immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer: a prospective observational study using digital tongue diagnosis.
Eunbyul Cho, Woosu Choi, Jun Hyeok Lim, Ji Woong Son, Seung Hun Jang, In-Jae Oh

Oncol Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying lung adenocarcinoma risk with multi-ancestry polygenic risk scores in East Asian never-smokers.
Batel Blechter, Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Hideo Kunitoh, Yohei Miyagi, Yoichi Ohtaki, In-Jae Oh, Mattias Johansson, John K Field, John K C Chan, Takashi Kohno

J Natl Cancer Inst· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients.
Min Jee Kim, Hyun Seok Kwak, Eun Nim Koh, Cheol-Kyu Park, Young-Chul Kim, In-Jae Oh

Thorac Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers.
Batel Blechter, Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Hideo Kunitoh, Yohei Miyagi, Yoichi Ohtaki, In-Jae Oh, Mattias Johansson, John K Field, John K C Chan, Takashi Kohno

medRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in retreatment of patients without T790M.
Juwhan Choi, Jae Cheol Lee, In Ae Kim, Kye Young Lee, Jeong Eun Lee, In-Jae Oh

Transl Lung Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Onset Crizotinib-Associated Renal Cysts With Subsequent Regression Following Dose Reduction: A Case Report.
Joon-Young Yoon, Won Gi Jeong, Yoo-Duk Choi, Seung Ji Kang, Hwa Kyung Park, Hyung-Joo Oh, In-Jae Oh

Thorac Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive accumulation of circulating CD27CD28 effector/memory CD8 T cells in patients with lung cancer blunts responses to immune checkpoint inhibitor therapy.
Sung-Woo Lee, Ju Sik Yun, Young Ju Kim, Saei Jeong, Jeong Eun Noh, In-Jae Oh

Exp Mol Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report.
Batel Blechter, Chao Agnes Hsiung, Xiaoyu Wang, Haoyu Zhang, Wei Jie Seow, Hideo Kunitoh, Yohei Miyagi, In-Jae Oh, John K C Chan, Takashi Kohno

J Thorac Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better Chemotherapeutic Response of Small Cell Lung Cancer in Never Smokers than in Smokers.
Ha-Young Park, Hyung-Joo Oh, Hwa Kyung Park, Joon-Young Yoon, Chang-Seok Yoon, In-Jae Oh

Tuberc Respir Dis (Seoul)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer.
Manh-Cuong Vo, Van-Tan Nguyen, Van-Dinh-Huan Tran, Hyung-Joo Oh, Sung-Hoon Jung, In-Jae Oh

Cancer Immunol Immunother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Profiling of Tumor Extracellular Vesicle-Associated RNAs Directly from Unprocessed Blood Plasma.
Elizabeth Maria Clarissa, Sumit Kumar, Juhee Park, Mamata Karmacharya, In-Jae Oh

ACS Nano· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer.
Sung-Woo Lee, Saei Jeong, Young Ju Kim, Jeong Eun Noh, Kyung Na Rho, In-Jae Oh

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Lung Cancer in Korean Never-Smokers With Polygenic Risk Scores.
Juyeon Kim, Young Sik Park, Jin Hee Kim, Yun-Chul Hong, Young-Chul Kim, In-Jae Oh

Genet Epidemiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti-PD-1 therapy.
Sung-Woo Lee, Young Ju Kim, Saei Jeong, Kyung Na Rho, Jeong Eun Noh, In-Jae Oh

Cancer Commun (Lond)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation.
Chang Dong Yeo, Dong Won Park, Seong Hoon Yoon, Eun Young Kim, Jeong Eun Lee, In-Jae Oh

Clin Respir J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic analysis on circulating T cells for early diagnosis of lung cancer.
Sung-Woo Lee, Young Ju Kim, Kyung Na Rho, Saei Jeong, Jeong Eun Noh, In-Jae Oh

Biomark Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower respiratory tract microbiome is associated with checkpoint inhibitor pneumonitis in lung cancer patients.
Dongming Zhang, Junping Fan, Xiaoyan Liu, Xiaoxing Gao, Qing Zhou, In-Jae Oh

Transl Lung Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Score Predicts Survival Benefit of Immunotherapy in Patients with Non-small Cell Lung Cancer.
Da Hyun Kang, Chang-Min Choi, Cheol-Kyu Park, In-Jae Oh, Young-Chul Kim

Tuberc Respir Dis (Seoul)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8 T cells in murine models of inflammation.
Gil-Woo Lee, Young Ju Kim, Sung-Woo Lee, Hee-Ok Kim, Daeun Kim, In-Jae Oh

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial.
Hyung-Joo Oh, Suk-Chul Bae, In-Jae Oh, Cheol-Kyu Park, Kyoung-Mi Jung

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Lymphocytes as a Prognostic Factor for Stage III Non-Small Cell Lung Cancer with Concurrent Chemoradiation.
Yong-Hyub Kim, Yoo-Duk Choi, Sung-Ja Ahn, Young-Chul Kim, In-Jae Oh

Chonnam Med J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer.
Hyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, Eun Young Kim, Seong Hoon Yoon

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
Wenping Song, Xuan Wu, Shuai Wang, Martin P Barr, María Rodríguez, In-Jae Oh

Transl Lung Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis